Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease

  • Park, Ji Sook (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Seo, Ji Hyun (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Youn, Hee-Shang (Department of Pediatrics, Gyeongsang National University School of Medicine)
  • Received : 2013.02.27
  • Accepted : 2013.03.08
  • Published : 2013.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.

Keywords

References

  1. Conterno L, Fava F, Viola R, Tuohy KM. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 2011;6:241-60. https://doi.org/10.1007/s12263-011-0230-1
  2. Oh K, Jang MJ, Lee NY, Moon JS, Lee CG, Yoo MH, et al. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatr 2008;51:950-5. https://doi.org/10.3345/kjp.2008.51.9.950
  3. Cho SJ, Kim EY, Rho YI, Yang ES, Park YB, Moon KR, et al. The long-term follow-up studies of childhood obesity after puberty. Korean J Pediatr Gastroenterol Nutr 2003;6:47-53.
  4. Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr 2011;35(5 Suppl):14S-20S. https://doi.org/10.1177/0148607111413772
  5. Chang JH, Kim DH, Kim HS, Choi IK, Cheong MY, Kim DK. Prevalence of metabolic syndrome in obese children. Korean J Pediatr 2004;47:1149-56.
  6. Nho HN, Kim CR, Uhm JH, Kim JT, Jin SM, Seo JY, et al. The prevalence of obesity and metabolic abnormalities in Korean pediatric population. Korean J Pediatr Gastroenterol Nutr 2009;12:207-14.
  7. Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology 2009;136:1476-83. https://doi.org/10.1053/j.gastro.2009.03.030
  8. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006;124:837-48. https://doi.org/10.1016/j.cell.2006.02.017
  9. Lyra A, Lahtinen S, Tiihonen K, Ouwehand AC. Intestinal microbiota and overweight. Benef Microbes 2010;1:407-21. https://doi.org/10.3920/BM2010.0030
  10. Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010;7:691-701. https://doi.org/10.1038/nrgastro.2010.172
  11. Machado MV, Cortez-Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol 2012;11:440-9.
  12. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009;136:65-80. https://doi.org/10.1053/j.gastro.2008.10.080
  13. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005;307:1915-20. https://doi.org/10.1126/science.1104816
  14. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012;148:1258-70. https://doi.org/10.1016/j.cell.2012.01.035
  15. Krznaric Z, Vranesic Bender D, Kunovic A, Kekez D, Stimac D. Gut microbiota and obesity. Dig Dis 2012;30:196-200. https://doi.org/10.1159/000336965
  16. Zoetendal EG, Vaughan EE, de Vos WM. A microbial world within us. Mol Microbiol 2006;59:1639-50. https://doi.org/10.1111/j.1365-2958.2006.05056.x
  17. Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 2011;12:272-81. https://doi.org/10.1111/j.1467-789X.2010.00797.x
  18. Ottman N, Smidt H, de Vos WM, Belzer C. The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol 2012;2:104.
  19. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005;102:11070-5. https://doi.org/10.1073/pnas.0504978102
  20. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature 2009;457:480-4. https://doi.org/10.1038/nature07540
  21. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol 2010;26:5-11. https://doi.org/10.1097/MOG.0b013e328333d751
  22. Kalliomaki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008;87:534-8.
  23. Balamurugan R, George G, Kabeerdoss J, Hepsiba J, Chandragunasekaran AM, Ramakrishna BS. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br J Nutr 2010;103:335-8. https://doi.org/10.1017/S0007114509992182
  24. Karlsson CL, Onnerfalt J, Xu J, Molin G, Ahrne S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 2012;20:2257-61. https://doi.org/10.1038/oby.2012.110
  25. Luoto R, Kalliomaki M, Laitinen K, Delzenne NM, Cani PD, Salminen S, et al. Initial dietary and microbiological environments deviate in normal-weight compared to overweight children at 10 years of age. J Pediatr Gastroenterol Nutr 2011;52:90-5. https://doi.org/10.1097/MPG.0b013e3181f3457f
  26. Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) 2010;34:1531-7. https://doi.org/10.1038/ijo.2010.50
  27. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004;101:15718-23. https://doi.org/10.1073/pnas.0407076101
  28. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007;104:979-84. https://doi.org/10.1073/pnas.0605374104
  29. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31. https://doi.org/10.1038/nature05414
  30. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 2008;105:16767-72. https://doi.org/10.1073/pnas.0808567105
  31. Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J Nutr 2000;130:1314-9. https://doi.org/10.1093/jn/130.5.1314
  32. Delzenne NM, Cani PD. A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 2005;8:636-40. https://doi.org/10.1097/01.mco.0000171124.06408.71
  33. Piche T, des Varannes SB, Sacher-Huvelin S, Holst JJ, Cuber JC, Galmiche JP. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 2003;124:894-902. https://doi.org/10.1053/gast.2003.50159
  34. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-72. https://doi.org/10.2337/db06-1491
  35. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 2010;299:G440-8. https://doi.org/10.1152/ajpgi.00098.2010
  36. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091-103. https://doi.org/10.1136/gut.2008.165886
  37. Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011;140:976-86. https://doi.org/10.1053/j.gastro.2010.11.049
  38. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000;119:1340-7. https://doi.org/10.1053/gast.2000.19267
  39. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007;47:571-9.
  40. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A 2011;108 Suppl 1:4523-30. https://doi.org/10.1073/pnas.1006734107
  41. Sabate JM, Jouet P, Harnois F, Mechler C, Msika S, Grossin M, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 2008;18:371-7. https://doi.org/10.1007/s11695-007-9398-2
  42. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009;49:1877-87. https://doi.org/10.1002/hep.22848
  43. Verdam FJ, Rensen SS, Driessen A, Greve JW, Buurman WA. Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis. J Clin Gastroenterol 2011;45:149-52. https://doi.org/10.1097/MCG.0b013e3181e12c24
  44. Tsukumo DM, Carvalho BM, Carvalho-Filho MA, Saad MJ. Translational research into gut microbiota: new horizons in obesity treatment. Arq Bras Endocrinol Metabol 2009;53:139-44. https://doi.org/10.1590/S0004-27302009000200004
  45. Iacono A, Raso GM, Canani RB, Calignano A, Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem 2011;22:699-711. https://doi.org/10.1016/j.jnutbio.2010.10.002

Cited by

  1. Ignoring our evolution: the ‘pandemic’ of over‐nutrition and under‐activity. Not simply a metabolic syndrome? vol.69, pp.3, 2014, https://doi.org/10.1111/anae.12599
  2. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse vol.25, pp.9, 2014, https://doi.org/10.1007/s00335-014-9521-3
  3. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer vol.239, pp.11, 2013, https://doi.org/10.1177/1535370214538743
  4. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease vol.125, pp.1, 2013, https://doi.org/10.1172/jci76738
  5. Fecal microbiota analysis of obese dogs with underlying diseases: a pilot study vol.55, pp.3, 2015, https://doi.org/10.14405/kjvr.2015.55.3.205
  6. Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome vol.290, pp.49, 2013, https://doi.org/10.1074/jbc.m115.670331
  7. The role of bile acids in metabolic regulation vol.228, pp.3, 2013, https://doi.org/10.1530/joe-15-0469
  8. A study of the prebiotic-like effects of tomato juice consumption in rats with diet-induced non-alcoholic fatty liver disease (NAFLD) vol.8, pp.10, 2017, https://doi.org/10.1039/c7fo00393e
  9. Extracts of Salvia-Nelumbinis Naturalis Ameliorate Nonalcoholic Steatohepatitis via Inhibiting Gut-Derived Endotoxin Mediated TLR4/NF- κ B Activation vol.2017, pp.None, 2013, https://doi.org/10.1155/2017/9208314
  10. Different Intestinal Microbial Profile in Over-Weight and Obese Subjects Consuming a Diet with Low Content of Fiber and Antioxidants vol.9, pp.6, 2013, https://doi.org/10.3390/nu9060551
  11. Gut microbiota: a new path to treat obesity vol.9, pp.1, 2013, https://doi.org/10.1038/s41367-019-0011-7
  12. Nonalcoholic fatty liver disease in obese and nonobese pediatric patients vol.62, pp.1, 2013, https://doi.org/10.3345/kjp.2018.06786
  13. El Niño Altered Gut Microbiota of Children: A New Insight on Weather-Gut Interactions and Protective Effects of Probiotic vol.22, pp.3, 2013, https://doi.org/10.1089/jmf.2018.4276
  14. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity vol.111, pp.4, 2013, https://doi.org/10.17235/reed.2019.6068/2018
  15. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD) vol.10, pp.4, 2019, https://doi.org/10.1039/c8fo01630e
  16. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms vol.330, pp.None, 2013, https://doi.org/10.1016/j.cbi.2020.109199
  17. The Potential Mediation of the Effects of Physical Activity on Cognitive Function by the Gut Microbiome vol.5, pp.4, 2013, https://doi.org/10.3390/geriatrics5040063